Vickerman & Driscoll Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$1.96M Buy
63,252
+22,756
+56% +$775K 1.2% 26
2019
Q4
$1.5M Sell
40,496
-85
-0.2% -$3.03K 0.76% 37
2019
Q3
$1.38M Hold
40,581
0.76% 42
2019
Q2
$1.67M Sell
40,581
-97
-0.2% -$3.85K 0.92% 39
2019
Q1
$1.64M Sell
40,678
-2,597
-6% -$104K 0.92% 36
2018
Q4
$1.79M Buy
43,275
+3,424
+9% +$142K 1.39% 19
2018
Q3
$1.67M Sell
39,851
-2,399
-6% -$92.4K 1.16% 25
2018
Q2
$1.45M Sell
42,250
-14
-0% -$478 1.06% 29
2018
Q1
$1.42M Buy
42,264
+2,929
+7% +$101K 1.05% 27
2017
Q4
$1.35M Buy
+39,335
New +$1.34M 1.06% 28

Other funds holding PFE

Vickerman & Driscoll Financial Advisors's PFE Position: Q1 2020 in Review

Vickerman & Driscoll Financial Advisors increased its Pfizer (PFE) stake by 56% in Q1 2020, buying an estimated $775K and bringing the position to 63,252 shares worth $1.96M. The position accounts for 1.2% of the portfolio, ranked #26.

Vickerman & Driscoll Financial Advisors first reported a position in PFE in Q4 2017 and has held it in 10 quarters since. 2,438 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Vickerman & Driscoll Financial Advisors held 63,252 shares of Pfizer worth $1.96M as of Q1 2020.
  • Vickerman & Driscoll Financial Advisors bought 22,756 Pfizer shares in Q1 2020, an estimated $775K.
  • Pfizer made up 1.2% of Vickerman & Driscoll Financial Advisors's portfolio in Q1 2020, its #26 holding.
  • Vickerman & Driscoll Financial Advisors first reported a position in Pfizer in Q4 2017 and has held it in 10 quarters since.
  • 2,438 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Vickerman & Driscoll Financial Advisors's 13F filing for Q1 2020, filed 13 May 2020.